{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:51:58Z","timestamp":1788997918750,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"DOI":"10.7759\/cureus.63379","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:36:59Z","timestamp":1721399819000},"source":"Crossref","is-referenced-by-count":11,"title":["The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies"],"prefix":"10.7759","author":[{"given":"Pacelli C","family":"Osigwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwudike E","family":"Agomoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifunanya S","family":"Osigwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence K","family":"Akumiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214065","article-title":"Prevalence and incidence of psoriasis and psoriatic arthritis","volume":"78","author":"Sewerin P","year":"2019","unstructured":"Sewerin P, Brinks R, Schneider M, Haase I, Vordenb\u00e4umen S. Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2019, 78:286-7. 10.1136\/annrheumdis-2018-214065","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths CE","year":"2021","unstructured":"Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. Lancet. 2021, 397:1301-15. 10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12230","article-title":"Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort","volume":"168","author":"Danielsen K","year":"2013","unstructured":"Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013, 168:1303-10. 10.1111\/bjd.12230","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028116","article-title":"Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort","volume":"9","author":"Egeberg A","year":"2019","unstructured":"Egeberg A, Andersen YM, Thyssen JP. Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort. BMJ Open. 2019, 9:e028116. 10.1136\/bmjopen-2018-028116","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi R","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013, 133:377-85. 10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2017.29.4.462","article-title":"The clinical profile of patients with psoriasis in Korea: a nationwide cross-sectional study (EPI-PSODE)","volume":"29","author":"Song HJ","year":"2017","unstructured":"Song HJ, Park CJ, Kim TY, et al.. The clinical profile of patients with psoriasis in Korea: a nationwide cross-sectional study (EPI-PSODE). Ann Dermatol. 2017, 29:462-70. 10.5021\/ad.2017.29.4.462","journal-title":"Ann Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis--epidemiology and clinical spectrum","volume":"26","author":"Christophers E","year":"2001","unstructured":"Christophers E. Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol. 2001, 26:314-20. 10.1046\/j.1365-2230.2001.00832.x","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study","volume":"141","author":"Gelfand JM","year":"2005","unstructured":"Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005, 141:1537-41. 10.1001\/archderm.141.12.1537","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.007","article-title":"Psoriasis: epidemiology","volume":"25","author":"Gudjonsson JE","year":"2007","unstructured":"Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007, 25:535-46. 10.1016\/j.clindermatol.2007.08.007","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180","article-title":"The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 study","volume":"8","author":"Damiani G","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, et al.. The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 study. Front Med (Lausanne). 2021, 8:743180. 10.3389\/fmed.2021.743180","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1993.tb01378.x","article-title":"Psoriasis in China","volume":"20","author":"Lin XR","year":"1993","unstructured":"Lin XR. Psoriasis in China. J Dermatol. 1993, 20:746-55. 10.1111\/j.1346-8138.1993.tb01378.x","journal-title":"J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(02)00142-1","article-title":"A survey of psoriasis patients in Japan from 1982 to 2001","volume":"31","author":"Kawada A","year":"2003","unstructured":"Kawada A, Tezuka T, Nakamizo Y, et al.. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci. 2003, 31:59-64. 10.1016\/s0923-1811(02)00142-1","journal-title":"J Dermatol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.01145.x","article-title":"Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008","volume":"38","author":"Takahashi H","year":"2011","unstructured":"Takahashi H, Nakamura K, Kaneko F, Nakagawa H, Iizuka H. Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008. J Dermatol. 2011, 38:1125-9. 10.1111\/j.1346-8138.2010.01145.x","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.03.002","article-title":"Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan","volume":"63","author":"Tsai TF","year":"2011","unstructured":"Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, Tang CH. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011, 63:40-6. 10.1016\/j.jdermsci.2011.03.002","journal-title":"J Dermatol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0458","article-title":"Role of adipokines in cardiovascular disease","volume":"81","author":"Lau WB","year":"2017","unstructured":"Lau WB, Ohashi K, Wang Y, Ogawa H, Murohara T, Ma XL, Ouchi N. Role of adipokines in cardiovascular disease. Circ J. 2017, 81:920-8. 10.1253\/circj.CJ-17-0458","journal-title":"Circ J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.7.284","article-title":"Pathogenic mechanisms shared between psoriasis and cardiovascular disease","volume":"7","author":"Ghazizadeh R","year":"2010","unstructured":"Ghazizadeh R, Shimizu H, Tosa M, Ghazizadeh M. Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int J Med Sci. 2010, 7:284-9. 10.7150\/ijms.7.284","journal-title":"Int J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment","volume":"18","author":"Hu SC","year":"2017","unstructured":"Hu SC, Lan CE. Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci. 2017, 18:2211. 10.3390\/ijms18102211","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00863.x","article-title":"C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis","volume":"18","author":"Chodorowska G","year":"2004","unstructured":"Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M. C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol. 2004, 18:180-3. 10.1111\/j.1468-3083.2004.00863.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03527.x","article-title":"C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy","volume":"24","author":"Coimbra S","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, et al.. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010, 24:789-96. 10.1111\/j.1468-3083.2009.03527.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2122w","article-title":"The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations","volume":"7","author":"Durante A","year":"2015","unstructured":"Durante A, Bronzato S. The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res. 2015, 7:379-84. 10.14740\/jocmr2122w","journal-title":"J Clin Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study","volume":"125","author":"Naldi L","year":"2005","unstructured":"Naldi L, Chatenoud L, Linder D, et al.. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005, 125:61-7. 10.1111\/j.0022-202X.2005.23681.x","journal-title":"J Invest Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer DM","year":"2006","unstructured":"Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006, 298:321-8. 10.1007\/s00403-006-0703-z","journal-title":"Arch Dermatol Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi P","year":"2007","unstructured":"Gisondi P, Tessari G, Conti A, et al.. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007, 157:68-73. 10.1111\/j.1365-2133.2007.07986.x","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.021","article-title":"Comorbidities in patients with psoriasis","volume":"122","author":"Gottlieb AB","year":"2009","unstructured":"Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009, 122:1150.e1-9. 10.1016\/j.amjmed.2009.06.021","journal-title":"Am J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.48","article-title":"Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses","volume":"145","author":"Qureshi AA","year":"2009","unstructured":"Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009, 145:379-82. 10.1001\/archdermatol.2009.48","journal-title":"Arch Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03564.x","article-title":"Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies","volume":"24 Suppl 2","author":"Prey S","year":"2010","unstructured":"Prey S, Paul C, Bronsard V, et al.. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol. 2010, 24 Suppl 2:23-30. 10.1111\/j.1468-3083.2009.03564.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta NN","year":"2012","unstructured":"Mehta NN, Li R, Krishnamoorthy P, et al.. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 2012, 224:218-21. 10.1016\/j.atherosclerosis.2012.06.068","journal-title":"Atherosclerosis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand JM","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006, 296:1735-41. 10.1001\/jama.296.14.1735","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000121333","article-title":"Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002","volume":"217","author":"Kimball AB","year":"2008","unstructured":"Kimball AB, Robinson D Jr, Wu Y, et al.. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology. 2008, 217:27-37. 10.1159\/000121333","journal-title":"Dermatology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand JM","year":"2009","unstructured":"Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009, 129:2411-8. 10.1038\/jid.2009.112","journal-title":"J Invest Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality","volume":"145","author":"Prodanovich S","year":"2009","unstructured":"Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009, 145:700-3. 10.1001\/archdermatol.2009.94","journal-title":"Arch Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.08.022","article-title":"Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis","volume":"123","author":"Kimball AB","year":"2010","unstructured":"Kimball AB, Guerin A, Latremouille-Viau D, Yu AP, Gupta S, Bao Y, Mulani P. Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med. 2010, 123:350-7. 10.1016\/j.amjmed.2009.08.022","journal-title":"Am J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta NN","year":"2010","unstructured":"Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010, 31:1000-6. 10.1093\/eurheartj\/ehp567","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10494.x","article-title":"Medical comorbidity associated with psoriasis in adults: a population-based study","volume":"165","author":"Yang YW","year":"2011","unstructured":"Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011, 165:1037-43. 10.1111\/j.1365-2133.2011.10494.x","journal-title":"Br J Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02310.x","article-title":"Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study","volume":"270","author":"Ahlehoff O","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M, et al.. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011, 270:147-57. 10.1111\/j.1365-2796.2010.02310.x","journal-title":"J Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study","volume":"33","author":"Ahlehoff O","year":"2012","unstructured":"Ahlehoff O, Gislason GH, J\u00f8rgensen CH, et al.. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study. Eur Heart J. 2012, 33:2054-64. 10.1093\/eurheartj\/ehr285","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary artery disease in patients with psoriasis referred for coronary angiography","volume":"109","author":"Armstrong AW","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Ledo L, Rogers JH, Armstrong EJ. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol. 2012, 109:976-80. 10.1016\/j.amjcard.2011.11.025","journal-title":"Am J Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01401.x","article-title":"Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study","volume":"39","author":"Chiang CH","year":"2012","unstructured":"Chiang CH, Huang CC, Chan WL, et al.. Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study. J Dermatol. 2012, 39:279-81. 10.1111\/j.1346-8138.2011.01401.x","journal-title":"J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10774.x","article-title":"Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study","volume":"166","author":"Li WQ","year":"2012","unstructured":"Li WQ, Han JL, Manson JE, Rimm EB, Rexrode KM, Curhan GC, Qureshi AA. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol. 2012, 166:811-8. 10.1111\/j.1365-2133.2011.10774.x","journal-title":"Br J Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04071.x","article-title":"Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study","volume":"26","author":"Maradit-Kremers H","year":"2012","unstructured":"Maradit-Kremers H, Icen M, Ernste FC, Dierkhising RA, McEvoy MT. Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study. J Eur Acad Dermatol Venereol. 2012, 26:336-43. 10.1111\/j.1468-3083.2011.04071.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.8","article-title":"Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures","volume":"135","author":"Koch M","year":"2015","unstructured":"Koch M, Baurecht H, Ried JS, et al.. Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol. 2015, 135:1283-93. 10.1038\/jid.2015.8","journal-title":"J Invest Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie A","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, et al.. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015, 74:326-32. 10.1136\/annrheumdis-2014-205675","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149316","article-title":"Association between psoriasis vulgaris and coronary heart disease in a hospital-based population in Japan","volume":"11","author":"Shiba M","year":"2016","unstructured":"Shiba M, Kato T, Funasako M, et al.. Association between psoriasis vulgaris and coronary heart disease in a hospital-based population in Japan. PLoS One. 2016, 11:e0149316. 10.1371\/journal.pone.0149316","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1136540","article-title":"Association between psoriasis and peripheral artery occlusive disease: a population-based retrospective cohort study","volume":"10","author":"Yeh CB","year":"2023","unstructured":"Yeh CB, Yeh LT, Yang SF, Wang BY, Wang YH, Chan CH. Association between psoriasis and peripheral artery occlusive disease: a population-based retrospective cohort study. Front Cardiovasc Med. 2023, 10:1136540. 10.3389\/fcvm.2023.1136540","journal-title":"Front Cardiovasc Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1023\/b:ejep.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris L","year":"2004","unstructured":"Mallbris L, Akre O, Granath F, Yin L, Lindel\u00f6f B, Ekbom A, St\u00e5hle-B\u00e4ckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004, 19:225-30. 10.1023\/b:ejep.0000020447.59150.f9","journal-title":"Eur J Epidemiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli YB","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009, 160:1048-56. 10.1111\/j.1365-2133.2008.09020.x","journal-title":"Br J Dermatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0688","article-title":"Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study","volume":"89","author":"Wakkee M","year":"2009","unstructured":"Wakkee M, Meijer W, Neumann HA, Herings RM, Nijsten T. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study. Acta Derm Venereol. 2009, 89:476-83. 10.2340\/00015555-0688","journal-title":"Acta Derm Venereol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03537.x","article-title":"Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample","volume":"24","author":"Schmitt J","year":"2010","unstructured":"Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol. 2010, 24:885-92. 10.1111\/j.1468-3083.2009.03537.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.321","article-title":"Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort","volume":"130","author":"Wakkee M","year":"2010","unstructured":"Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol. 2010, 130:962-7. 10.1038\/jid.2009.321","journal-title":"J Invest Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.399","article-title":"Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk","volume":"131","author":"Stern RS","year":"2011","unstructured":"Stern RS, Huibregtse A. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol. 2011, 131:1159-66. 10.1038\/jid.2010.399","journal-title":"J Invest Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.046","article-title":"Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis","volume":"66","author":"Shapiro J","year":"2012","unstructured":"Shapiro J, Cohen AD, Weitzman D, Tal R, David M. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. J Am Acad Dermatol. 2012, 66:252-8. 10.1016\/j.jaad.2010.11.046","journal-title":"J Am Acad Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.131","article-title":"Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study","volume":"133","author":"Dowlatshahi EA","year":"2013","unstructured":"Dowlatshahi EA, Kavousi M, Nijsten T, Ikram MA, Hofman A, Franco OH, Wakkee M. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. J Invest Dermatol. 2013, 133:2347-54. 10.1038\/jid.2013.131","journal-title":"J Invest Dermatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.87","article-title":"Psoriasis and the risk of major cardiovascular events: cohort study using the Clinical Practice Research Datalink","volume":"135","author":"Parisi R","year":"2015","unstructured":"Parisi R, Rutter MK, Lunt M, Young HS, Symmons DP, Griffiths CE, Ashcroft DM. Psoriasis and the risk of major cardiovascular events: cohort study using the Clinical Practice Research Datalink. J Invest Dermatol. 2015, 135:2189-97. 10.1038\/jid.2015.87","journal-title":"J Invest Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab173","article-title":"Psoriasis and coronary heart disease-not as severe as predicted","volume":"115","author":"Hadi Y","year":"2022","unstructured":"Hadi Y, Or T, Moady G, Atar S. Psoriasis and coronary heart disease-not as severe as predicted. QJM. 2022, 115:388-92. 10.1093\/qjmed\/hcab173","journal-title":"QJM"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12002","article-title":"Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies","volume":"167","author":"Xu T","year":"2012","unstructured":"Xu T, Zhang YH. Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies. Br J Dermatol. 2012, 167:1345-50. 10.1111\/bjd.12002","journal-title":"Br J Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong EJ","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013, 2:e000062. 10.1161\/JAHA.113.000062","journal-title":"J Am Heart Assoc"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27 Suppl 3","author":"Horreau C","year":"2013","unstructured":"Horreau C, Pouplard C, Brenaut E, et al.. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013, 27 Suppl 3:12-29. 10.1111\/jdv.12163","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller IM","year":"2013","unstructured":"Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013, 69:1014-24. 10.1016\/j.jaad.2013.06.053","journal-title":"J Am Acad Dermatol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis","volume":"133","author":"Samarasekera EJ","year":"2013","unstructured":"Samarasekera EJ, Neilson JM, Warren RB, Parnham J, Smith CH. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. J Invest Dermatol. 2013, 133:2340-6. 10.1038\/jid.2013.149","journal-title":"J Invest Dermatol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.829709","article-title":"Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study","volume":"9","author":"Liu L","year":"2022","unstructured":"Liu L, Cui S, Liu M, Huo X, Zhang G, Wang N. Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study. Front Cardiovasc Med. 2022, 9:829709. 10.3389\/fcvm.2022.829709","journal-title":"Front Cardiovasc Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-9, W64. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung H","year":"2013","unstructured":"Yeung H, Takeshita J, Mehta NN, et al.. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013, 149:1173-9. 10.1001\/jamadermatol.2013.5015","journal-title":"JAMA Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs114","article-title":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes","volume":"33","author":"Dahabreh IJ","year":"2012","unstructured":"Dahabreh IJ, Sheldrick RC, Paulus JK, et al.. Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. Eur Heart J. 2012, 33:1893-901. 10.1093\/eurheartj\/ehs114","journal-title":"Eur Heart J"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03318.x","article-title":"Prevalence of myocardial infarction in patients with psoriasis in central China","volume":"23","author":"Xiao J","year":"2009","unstructured":"Xiao J, Chen LH, Tu YT, Deng XH, Tao J. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009, 23:1311-5. 10.1111\/j.1468-3083.2009.03318.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307449","article-title":"Nationwide study on the risk of abdominal aortic aneurysms in patients with psoriasis","volume":"36","author":"Khalid U","year":"2016","unstructured":"Khalid U, Egeberg A, Ahlehoff O, Smedegaard L, Gislason GH, Hansen PR. Nationwide study on the risk of abdominal aortic aneurysms in patients with psoriasis. Arterioscler Thromb Vasc Biol. 2016, 36:1043-8. 10.1161\/ATVBAHA.116.307449","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.050","article-title":"Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan","volume":"64","author":"Lin HW","year":"2011","unstructured":"Lin HW, Wang KH, Lin HC, Lin HC. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. J Am Acad Dermatol. 2011, 64:495-501. 10.1016\/j.jaad.2010.01.050","journal-title":"J Am Acad Dermatol"},{"key":"ref70","doi-asserted-by":"crossref","DOI":"10.5070\/D32410041706","article-title":"Incidence rates of comorbidities among patients with psoriasis in the United States","volume":"24","author":"Feldman SR","year":"2018","unstructured":"Feldman SR, Hur P, Zhao Y, Tian H, Wei Z, Wang X, Herrera V. Incidence rates of comorbidities among patients with psoriasis in the United States. Dermatol Online J. 2018, 24:","journal-title":"Dermatol Online J"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05430.x","article-title":"Risk and predictors of cardiovascular disease in psoriasis: a population-based study","volume":"52","author":"Maradit-Kremers H","year":"2013","unstructured":"Maradit-Kremers H, Dierkhising RA, Crowson CS, Icen M, Ernste FC, McEvoy MT. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol. 2013, 52:32-40. 10.1111\/j.1365-4632.2011.05430.x","journal-title":"Int J Dermatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2014.952609","article-title":"Risk of myocardial infarction in psoriasis patients: a retrospective cohort study","volume":"26","author":"Wu JJ","year":"2015","unstructured":"Wu JJ, Choi YM, Bebchuk JD. Risk of myocardial infarction in psoriasis patients: a retrospective cohort study. J Dermatolog Treat. 2015, 26:230-4. 10.3109\/09546634.2014.952609","journal-title":"J Dermatolog Treat"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.06.002","article-title":"Increased risk of aortic aneurysm (AA) in relation to the severity of psoriasis: a national population-based matched-cohort study","volume":"75","author":"Chiu HY","year":"2016","unstructured":"Chiu HY, Lo PC, Huang WF, Tsai YW, Tsai TF. Increased risk of aortic aneurysm (AA) in relation to the severity of psoriasis: a national population-based matched-cohort study. J Am Acad Dermatol. 2016, 75:747-54. 10.1016\/j.jaad.2016.06.002","journal-title":"J Am Acad Dermatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15052","article-title":"Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: a 15-year nationwide population-based cohort study","volume":"46","author":"Jung KJ","year":"2019","unstructured":"Jung KJ, Kim TG, Lee JW, et al.. Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: a 15-year nationwide population-based cohort study. J Dermatol. 2019, 46:859-66. 10.1111\/1346-8138.15052","journal-title":"J Dermatol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2013.13052","article-title":"Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study","volume":"17","author":"Levesque A","year":"2013","unstructured":"Levesque A, Lachaine J, Bissonnette R. Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study. J Cutan Med Surg. 2013, 17:398-403. 10.2310\/7750.2013.13052","journal-title":"J Cutan Med Surg"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2657","article-title":"Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a nationwide cohort study","volume":"97","author":"Egeberg A","year":"2017","unstructured":"Egeberg A, Thyssen JP, Jensen P, Gislason GH, Skov L. Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a nationwide cohort study. Acta Derm Venereol. 2017, 97:819-24. 10.2340\/00015555-2657","journal-title":"Acta Derm Venereol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15021","article-title":"Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study","volume":"32","author":"Leisner MZ","year":"2018","unstructured":"Leisner MZ, Lindorff Riis J, Gniadecki R, Iversen L, Olsen M. Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study. J Eur Acad Dermatol Venereol. 2018, 32:2185-90. 10.1111\/jdv.15021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan A","year":"2014","unstructured":"Dregan A, Charlton J, Chowienczyk P, Gulliford MC. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation. 2014, 130:837-44. 10.1161\/CIRCULATIONAHA.114.009990","journal-title":"Circulation"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne JA","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, et al.. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 343:d4002. 10.1136\/bmj.d4002","journal-title":"BMJ"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23438","article-title":"Risk of aortic aneurysm in patients with psoriasis: a systematic review and meta-analysis of cohort studies","volume":"43","author":"Yu X","year":"2020","unstructured":"Yu X, Feng X, Xia L, Cao S, Wei X. Risk of aortic aneurysm in patients with psoriasis: a systematic review and meta-analysis of cohort studies. Clin Cardiol. 2020, 43:1266-72. 10.1002\/clc.23438","journal-title":"Clin Cardiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.02.020","article-title":"Adiponectin and atherosclerotic disease","volume":"344","author":"Shimada K","year":"2004","unstructured":"Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta. 2004, 344:1-12. 10.1016\/j.cccn.2004.02.020","journal-title":"Clin Chim Acta"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1177\/24755303231199995","article-title":"Serum adiponectin levels as an independent marker of severity of psoriasis: a cross-sectional analysis","volume":"8","author":"Kaushik A","year":"2023","unstructured":"Kaushik A, Chopra D, Kaur K, Gupta S, Chopra P. Serum adiponectin levels as an independent marker of severity of psoriasis: a cross-sectional analysis. J Psoriasis Psoriatic Arthritis. 2023, 8:148-55. 10.1177\/24755303231199995","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"ref83","article-title":"Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation","volume":"9","author":"Ferreira BI","year":"2016","unstructured":"Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016, 9:36-43.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9708","article-title":"Association between psoriasis and depression: a traditional review","volume":"12","author":"Sahi FM","year":"2020","unstructured":"Sahi FM, Masood A, Danawar NA, Mekaiel A, Malik BH. Association between psoriasis and depression: a traditional review. Cureus. 2020, 12:e9708. 10.7759\/cureus.9708","journal-title":"Cureus"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha R","year":"2011","unstructured":"Micha R, Imamura F, Wyler von Ballmoos M, Solomon DH, Hern\u00e1n MA, Ridker PM, Mozaffarian D. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. 2011, 108:1362-70. 10.1016\/j.amjcard.2011.06.054","journal-title":"Am J Cardiol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"148","author":"Wu JJ","year":"2012","unstructured":"Wu JJ, Poon KY, Channual JC, Shen AY. Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. Arch Dermatol. 2012, 148:1244-50. 10.1001\/archdermatol.2012.2502","journal-title":"Arch Dermatol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon DH","year":"2011","unstructured":"Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011, 305:2525-31. 10.1001\/jama.2011.878","journal-title":"JAMA"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.020031","article-title":"Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis","volume":"49","author":"Ornello R","year":"2018","unstructured":"Ornello R, Degan D, Tiseo C, et al.. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018, 49:814-9. 10.1161\/STROKEAHA.117.020031","journal-title":"Stroke"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter A","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, et al.. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008, 58:826-50. 10.1016\/j.jaad.2008.02.039","journal-title":"J Am Acad Dermatol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina TB","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods. 2006, 11:193-206. 10.1037\/1082-989X.11.2.193","journal-title":"Psychol Methods"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/241172-the-association-between-psoriasis-and-atherosclerotic-cardiovascular-disease-a-systematic-review-and-meta-analysis-of-observational-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:37:04Z","timestamp":1721399824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/241172-the-association-between-psoriasis-and-atherosclerotic-cardiovascular-disease-a-systematic-review-and-meta-analysis-of-observational-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":90,"URL":"https:\/\/doi.org\/10.7759\/cureus.63379","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}